The drug testing industry is set to be worth an estimated $6.3 billion by 2019, up from $4 billion in 2014, growing at a CAGR of 9.5% from 2014 to 2019, according to a recently released report.
The “Drug Screening Market by Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat) – Global Forecast to 2019″ report takes an in-depth look at the drug testing market. It explores the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the drug and alcohol testing market along with estimates and forecasts of the revenue and share analysis.
The report segments the drug and alcohol testing market on the basis of
- products and services,
- sample types,
- end users, and
Some highlights from the report include:
- Urine samples accounted for the largest share in 2014.
- The breath sample segment will grow at the highest CAGR in the forecast period.
- Breath testing is the most common test performed for driving under influence (DUI) cases.
- Factors such as the rise in the number of roadside accidents due to DUI and government initiatives to curb DUI are the factors driving the growth of drug and alcohol testing market for breath testing.
- The oral fluid testing segment has also gained prominence in the market due to the noninvasive nature of this test where samples can be collected under direct observation, which prevents adulteration of the sample.
- With oral fluid testing, the concentrations of many drugs can be closely correlated with blood concentrations.
Based on region, the market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in this market.
Click here to download the pdf of the report.